Ovarian Cancer Drug

A lot of stocks in the Nasdaq iShares Biotechnology Fund have been under pressure lately. I almost feel as if the sector has been pricing in a Hillary Clinton victory. I am not here to discuss politics though. I discuss stock charts and make bad jokes with really dry humor. Well,...